Tempus AI gains bullish ratings from Wall Street brokeragesAshley WangJuly 10, 2024 Wall Street has initiated bullish coverage on SoftBank-backed Tempus AI, forecasting growth driven by its AI-powered businesses.
SoftBank sets up AI healthcare joint venture with Tempus AIZora LinJune 28, 2024 OUR TAKE Tempus is committed to changing the precision medicine landscape through the practical application of AI, and the collaboration with…
Tempus AI’s IPO: investor confidence in genomics diagnosticsSissy LiJune 14, 2024 SoftBank Group backed TempusAI’s public offering, at $37 per share, will begin trading on Nasdaq Global Select on Friday.
